Miromatrix Medical Investor Relations Material
Latest events
Q2 2023
Miromatrix Medical
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Miromatrix Medical Inc
Access all reports
Miromatrix Medical Inc. is a biotechnology company focused on developing bioengineered organs and tissues for transplantation. The company uses its proprietary technology to create fully transplantable human organs, such as livers and kidneys, by repopulating decellularized animal organs with human cells. Miromatrix aims to address the global shortage of donor organs by providing alternative, lab-grown solutions for patients in need of transplants. The company's bioengineering platform is designed to produce organs that could potentially eliminate the need for immunosuppressive drugs post-transplant. The company is headquartered in Eden Prairie, Minnesota, and its shares are listed on the NASDAQ.
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
MIRO
Country
🇺🇸 United States